Bio-Techne Corp


Market Cap$9.78B

Compare Bio-Techne

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Bio-Techne CorpBio-Techne Corp43.60.51%11%9.10.2
marketMarket Avg591.3%30%-1
HealthcareHealthcare Avg64.41.34%15%-0.9

Current Fair Value

37.8% downside

Overvalued by 37.8% based on the discounted cash flow analysis.

Share Statistics

Market cap$9.78 Billion
Enterprise Value$10.09 Billion
Dividend Yield$0.3189 (0.51%)
Earnings per Share$1.39
Outstanding Shares157,191,685
Avg 30 Day Volume992,614


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio43.63
Price to Sales9.1
Price to Book Ratio5.31
Enterprise Value to Revenue8.81
Enterprise Value to EBIT38.33
Enterprise Value to Net Income45
Total Debt to Enterprise0.04
Debt to Equity0.23

Revenue Sources

No data

ESG Score

No data

About Bio-Techne Corp

2,100 employees
CEO: Charles Kummeth

Bio-Techne Corporation is a holding company for biotechnology and clinical diagnostic brands. It was founded in 1976 as Techne Corporation and changed its name to Bio-Techne in 2014. The company's brands include flagship R&D Systems , No...